Literature DB >> 2969202

A method for the determination of N-acetylglucosaminyltransferase III activity in rat tissues involving HPLC.

A Nishikawa1, S Fujii, T Sugiyama, N Taniguchi.   

Abstract

A fluorescence assay method for UDP-GlcNAc:glycopeptide beta 1-4 N-acetylglucosaminyltransferase (Gn T-III) has been developed involving a pyridylaminated sugar as a substrate. A fluorescent sugar chain, in which the reducing end of the GlcNAc beta 1-2Man alpha 1-6(GlcNAc beta 1-2Man alpha 1-3)Man beta 1-4GlcNAc beta 1-4GlcNAc has been aminated with 2-aminopyridine, is incubated with an enzyme sample, and then the fluorescent product with a bisecting N-acetylglucosamine is separated by reverse-phase high performance liquid chromatography and quantitated with a fluorescence detector. This assay method was found to be sensitive enough for the detection of 0.1 pmol of a reaction product. This assay is a reliable alternative to the use of a radiolabeled substrate and can be used for assaying N-acetylglucosaminyltransferase activity in crude extracts of various rat tissues. The kinetic experiments were carried out using crude enzyme extracts from the rat kidney. The enzyme has a pH optimum of 6.25 and requires Mn2+. The Km values for UDP-GlcNAc and a sugar acceptor substrate were found to be 3.1 mM and 190 microM, respectively. The enzyme activity in the rat kidney was higher than those in the other tissues examined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969202     DOI: 10.1016/0003-2697(88)90641-0

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

1.  An approach for fluorometric determination of glycosyltransferase activities.

Authors:  C A Palmerini; A Datti; I E Vanderelst; L Minuti; A Orlacchio
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

2.  Bisecting GlcNAc structure is implicated in suppression of stroma-dependent haemopoiesis in transgenic mice expressing N-acetylglucosaminyltransferase III.

Authors:  M Yoshimura; Y Ihara; T Nishiura; Y Okajima; M Ogawa; H Yoshida; M Suzuki; K Yamamura; Y Kanakura; Y Matsuzawa; N Taniguchi
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

3.  Determination of UDP-N-acetylglucosamine: beta-D-mannoside-1,4-N-acetylglucosaminyltransferase-III in patients sera with chronic hepatitis and liver cirrhosis using a monoclonal antibody.

Authors:  Eun-Young Song; Kyung-Sook Kim; Kyoung-A Kim; Yung-Dai Kim; Dur-Han Kwon; Si-Myung Byun; Hee-Jung Kim; Tae-Wook Chung; Yong-Kyung Choe; Tai-Wha Chung; Cheorl-Ho Kim
Journal:  Glycoconj J       Date:  2002-07       Impact factor: 2.916

4.  Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection.

Authors:  M Yoshimura; A Nishikawa; Y Ihara; S Taniguchi; N Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

5.  Changes of beta-1,4-N-acetylglucosaminyltransferase III (GnT-III) in patients with leukaemia.

Authors:  M Yoshimura; Y Ihara; N Taniguchi
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

6.  Deficiency of beta 1-6 N-acetylglucosaminyltransferase involved in the biosynthesis of blood group I antigen in the liver of LEC rats.

Authors:  J Gu; A Nishikawa; N Matsuura; T Sugiyama; N Taniguchi
Journal:  Jpn J Cancer Res       Date:  1992-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.